Experimental Drug Reverses Multiple Sclerosis Damage in Mouse Model
The experimental drug preserved nerve fibers and halted a nerve-damage biomarker in mice, and researchers said controlled human trials are needed.
5 Articles
5 Articles
A drug developed by a UVA Health scientist in the United States has not only slowed down, but has managed to reverse paralysis and vision loss in a mouse model with multiple sclerosis. The results, published in Science Translational Medicine, are especially relevant because current treatments for this disease are aimed at ... Continue reading "A drug derivative against HIV reverses paralysis and vision loss by multiple sclerosis"
An experimental drug regressed in mice the paralysis and blindness caused by multiple sclerosis. The result is described in a study published in the journal Science Translational Medicine and coordinated by Jayakrishna Ambati, University of Virginia. The drug, called Kamuvudine-9 (K-9), comes from an anti-Hiv antiretroviral molecule already approved for use in humans [...] L'articolo Sclerosis multiforme, the study on experimental drug that make…
Coverage Details
Bias Distribution
- 60% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
